UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 574.8	$ 645.5
Accounts receivable, net	450.8	472.7
Inventories	914.6	800.1
Assets held for sale	0.0	1.4
Other current assets	243.1	193.5
Total current assets	2,183.3	2,113.2
Property, plant and equipment, net	522.7	487.0
Goodwill	557.9	457.6
Intangible assets, net	300.4	270.9
Other long-term assets	292.7	283.1
Total assets	3,857.0	3,611.8
Current liabilities:
Current portion of long-term debt	120.9	18.7
Accounts payable	188.8	178.4
Deferred revenue and customer advances	397.4	370.2
Other current liabilities	343.8	347.0
Total current liabilities	1,050.9	914.3
Long-term debt	1,122.5	1,200.5
Other long-term liabilities	421.0	365.2
Commitments and contingencies (Note 16)
Redeemable noncontrolling interests	11.9	6.1
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 175,498,835 and 175,389,586 shares issued and 146,817,075 and 147,023,144 shares outstanding at June 30, 2023 and December 31, 2022, respectively	1.7	1.7
Treasury stock, at cost, 28,681,760 and 28,366,442 shares at June 30, 2023 and December 31, 2022, respectively	(1,107.2)	(1,085.0)
Accumulated other comprehensive income, net of tax	24.4	14.8
Other shareholders' equity	2,312.3	2,182.3
Total shareholders' equity attributable to Bruker Corporation	1,231.2	1,113.8
Noncontrolling interests in consolidated subsidiaries	19.5	11.9
Total shareholders' equity	1,250.7	1,125.7
Total liabilities, redeemable noncontrolling interests and shareholders' equity	$ 3,857.0	$ 3,611.8